Correlation Between Aerovate Therapeutics and ELYM Old

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and ELYM Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and ELYM Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and ELYM Old, you can compare the effects of market volatilities on Aerovate Therapeutics and ELYM Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of ELYM Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and ELYM Old.

Diversification Opportunities for Aerovate Therapeutics and ELYM Old

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aerovate and ELYM is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and ELYM Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ELYM Old and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with ELYM Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ELYM Old has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and ELYM Old go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and ELYM Old

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the ELYM Old. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 1.07 times less risky than ELYM Old. The stock trades about 0.0 of its potential returns per unit of risk. The ELYM Old is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  362.00  in ELYM Old on October 16, 2024 and sell it today you would lose (53.00) from holding ELYM Old or give up 14.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.14%
ValuesDaily Returns

Aerovate Therapeutics  vs.  ELYM Old

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics may actually be approaching a critical reversion point that can send shares even higher in February 2025.
ELYM Old 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ELYM Old has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Aerovate Therapeutics and ELYM Old Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and ELYM Old

The main advantage of trading using opposite Aerovate Therapeutics and ELYM Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, ELYM Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ELYM Old will offset losses from the drop in ELYM Old's long position.
The idea behind Aerovate Therapeutics and ELYM Old pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories